1.Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer
Naoya MURAKAMI ; Miho WATANABE ; Takashi UNO ; Shuhei SEKII ; Kayoko TSUJINO ; Takahiro KASAMATSU ; Yumiko MACHITORI ; Tomomi AOSHIKA ; Shingo KATO ; Hisako HIROWATARI ; Yuko KANEYASU ; Tomio NAKAGAWA ; Hitoshi IKUSHIMA ; Ken ANDO ; Masumi MURATA ; Ken YOSHIDA ; Hiroto YOSHIOKA ; Kazutoshi MURATA ; Tatsuya OHNO ; Noriyuki OKONOGI ; Anneyuko I. SAITO ; Mayumi ICHIKAWA ; Takahito OKUDA ; Keisuke TSUCHIDA ; Hideyuki SAKURAI ; Ryoichi YOSHIMURA ; Yasuo YOSHIOKA ; Atsunori YOROZU ; Naonobu KUNITAKE ; Hiroyuki OKAMOTO ; Koji INABA ; Tomoyasu KATO ; Hiroshi IGAKI ; Jun ITAMI
Journal of Gynecologic Oncology 2023;34(3):e24-
Objective:
The purposes of this trial were to demonstrate the feasibility and effectiveness of the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer patients in the phase I/II prospective clinical trial.
Methods:
Patients with FIGO stage IB2-IVA uterine cervical cancer pretreatment width of which was ≥5 cm measured by magnetic resonance imaging were eligible for this clinical trial. The protocol therapy included 30–30.6 Gy in 15–17 fractions of whole pelvic radiotherapy concurrent with weekly CDDP, followed by 24 Gy in 4 fractions of HBT and pelvic radiotherapy with a central shield up to 50–50.4 Gy in 25–28 fractions. The primary endpoint of phase II part was 2-year pelvic progression-free survival (PPFS) rate higher than historical control of 64%.
Results:
Between October 2015 and October 2019, 73 patients were enrolled in the initial registration and 52 patients proceeded to the secondary registration. With the median follow-up period of 37.3 months (range, 13.9–52.9 months), the 2- PPFS was 80.7% (90% confidence interval [CI]=69.7%–88%). Because the lower range of 90% CI of 2-year PPFS was 69.7%, which was higher than the historical control ICBT data of 64%, therefore, the primary endpoint of this study was met.
Conclusion
The effectiveness of HBT were demonstrated by a prospective clinical study. Because the dose goal determined in the protocol was lower than 85 Gy, there is room in improvement for local control. A higher dose might have been needed for tumors with poor responses.
2.Three-Dimensional Analysis of the Ideal Entry Point for Sacral Alar Iliac Screws
Noriyuki WATANABE ; Tomoyuki TAKIGAWA ; Koji UOTANI ; Yoshiaki ODA ; Haruo MISAWA ; Masato TANAKA ; Toshifumi OZAKI
Asian Spine Journal 2022;16(6):874-881
Methods:
Preoperative CT data from 26 patients pertaining to adult spinal deformities were investigated in this study. We applied a 3D image processing method for a detailed investigation. Virtual cylinders were used to mimic SAI screws. These were placed to penetrate the sacral iliac joint without violating the other cortex. We then assessed the trajectory of the longest SAI screw and the ideal entry point of SAI using a color mapping method on the surface of the sacrum. We measured the location of the nerve root at S1 in relation to the foramen at S1 and the sacral surface.
Results:
As per the results of our color mapping, it was determined that areas that received high scores are located medially and caudally to the dorsal foramen of S1. The mean angle between a horizontal line and a line connecting the medial edge of the foramen and nerve root at S1 was 93.5°. The mean distances from the dorsal medial edge of the foramen and sacral surface to S1 nerve root were 21.8 mm and 13.9 mm, respectively.
Conclusions
The ideal entry point of the SAI screw is located medially and caudally to the S1 dorsal foramen based on 3D digital mapping. It is also shown that this entry point spares the S1 nerve root from possible iatrogenic injuries.
3.The prevalence of psychological distress during pregnancy in Miyagi Prefecture for 3 years after the Great Eas t Japan Earthquake.
Kaou TANOUE ; Zen WATANABE ; Hidekazu NISHIGORI ; Noriyuki IWAMA ; Michihiro SATOH ; Takahisa MURAKAMI ; Kousuke TANAKA ; Satomi SASAKI ; Kasumi SAKURAI ; Mami ISHIKURO ; Taku OBARA ; Masatoshi SAITO ; Junichi SUGAWARA ; Nozomi TATSUTA ; Shinichi KURIYAMA ; Takahiro ARIMA ; Kunihiko NAKAI ; Nobuo YAEGASHI ; Hirohito METOKI
Environmental Health and Preventive Medicine 2021;26(1):27-27
BACKGROUND:
To examine changes in psychological distress prevalence among pregnant women in Miyagi Prefecture, which was directly affected by the Great East Japan Earthquake and tsunami, and compare it with the other, less damaged areas of Japan.
METHODS:
This study was conducted in conjunction with the Japan Environment and Children`s Study. We examined 76,152 pregnant women including 8270 in Miyagi Regional Center and 67,882 in 13 other regional centers from the all-birth fixed data of the Japan Environment and Children's Study. We then compared the prevalence and risk of distress in women in Miyagi Regional Center and women in the 13 regional centers for 3 years after the disaster.
RESULTS:
Women in the Miyagi Regional Center suffered more psychological distress than those in the 13 regional centers: OR 1.38 (95% CI, 1.03-1.87) to 1.92 (95% CI, 1.42-2.60). Additionally, women in the inland area had a consistently higher prevalence of psychological distress compared to those from the 13 regional centers: OR 1.67 (95% CI, 1.18-2.38) to 2.19 (95% CI, 1.60-2.99).
CONCLUSIONS
The lack of pre-disaster data in the Japan Environment and Children's Study made it impossible to compare the incidence of psychological distress before and after the March 2011 Great East Japan Earthquake. However, 3 years after the Great East Japan Earthquake, the prevalence of pregnant women with psychological distress did not improve in Miyagi Regional Center. Further, the prevalence of mental illness in inland areas was consistently higher than that in the 13 regional centers after the disaster.
Adolescent
;
Adult
;
Disasters
;
Earthquakes
;
Female
;
Humans
;
Japan/epidemiology*
;
Pregnancy
;
Pregnancy Complications/psychology*
;
Pregnant Women/psychology*
;
Prevalence
;
Psychological Distress
;
Tsunamis
;
Young Adult
4.A Survey of Japanese Consumersʼ Recognition and Consciousness of the Foods with Function Claims System
Noriyuki UJIIE ; Midori SHIMADA ; Koji NARUI ; Kinzo WATANABE
Japanese Journal of Drug Informatics 2018;20(2):104-110
Objective:After the start of the Foods with Function Claims system started in April 2015, the number of Foods withFunction Claims has increased every year. As such,the health food market in Japan is expanding and the health foods usedby consumers has been changing. To clarify the influence by which Foods with Function Claims has affected people’seating habits and improved their health, we surveyed people’s recognition and motivations to the Foods with FunctionClaims.Methods:Our survey was conducted with 238 consumers attending a sports club in the Tama area in western Tokyo,Japan.Results:In response to the question recognition of the word “Foods with Function Claims,”43 people(18.1%) responded“I know well,”141 people(59.2%)responded “I have heard it,but I do not know the meaning,”54 people(22.7%)responded“I do not know. I have never heard of it.” In response to the question whether to buy the Foods with Function Claims,77 people (32.4%) responded “I buy if the price is a little higher than not the Foods with Function Claims,”126 people(52.9%) responded “I buy if the price is equal to not the Foods with Function Claims.” In response to the question, 182people(76.5%)responded“I go to the hospital,”40 people(16.8%)responded“I do not go to the hospital and I use the Foodswith Function Claims.”Conclusion: Our results revealed that the recognition of Foods with Function Claims was low. However consumersrecognized that the Foods with Function Claims is worth using. Education to improve recognition for the Foods withFunction Claims is necessary.
5.Status of Responses to Foreign Language Inquiries When Selling OTC Drug
Noriyuki UJIIE ; Koji NARUI ; Katsuei WATANABE ; Kinzo WATANABE
Japanese Journal of Drug Informatics 2018;20(2):129-135
Objective: Along with the increase in the number of foreign visitors to Japan, the number of inquiries in foreign languages at the time of OTC drug sales has increased. To clarify the current status of responses to foreign language inquiries when selling OTC drug, we surveyed the frequency of foreign language response, languages used, trouble experienced, and preparation useful in responding to foreign language inquiries when selling OTC drug.Methods: Our survey was conducted with 694 registered salesclerks of drugs at an external training seminar in Tokyo, Japan.Results: Of the 649 respondents, 337 (51.9%) had experience in responding to inquiries in a foreign language when selling OTC drug. The languages used were as follows: ”English,” 86.4%; ”Chinese,” 70.0%; ”Korean,” 25.8%. Of the respondents who had experience in responding to inquiries in a foreign language when selling OTC drug, 107 (31.8%) responded ”I experienced trouble because I could not understand what was being said,” and 228 (67.7%) responded ”I could not respond and experienced trouble.” When asked about preparation/tools useful for selling OTC drug, 434 (66.9%) responded ”multilingual written correspondence table,” 359 (55.3%) responded ”smartphone or tablet‐based correspondence multilingual table,” 299 (46.1%) responded ”marks and illustrations,” and 253 (39.0%) responded ”I would like to be taught how to respond in a foreign language (simple conversation).”Conclusions: Our results revealed that when selling OTC drug, response to inquiries in a foreign language occurred frequently and trouble was experienced in listening comprehension and speaking a foreign language. Therefore, urgent countermeasures such as preparing a multilingual correspondence table of symptoms, usage, and dosage, and lectures on methods of responding through simple foreign language conversations are necessary. In addition, efforts such as creation of multilingual drug package inserts by pharmaceutical companies were considered to be an effective measure.
6.Accreditation of Physiology Educators by the Physiological Society of Japan
Akira Nakashima ; Noriyuki Koibuchi ; Masaru Ishimatsu ; Tetsu Okumura ; Michio Shiibashi ; Atsuko Suzuki ; Makino Watanabe
Medical Education 2014;45(6):415-420
A system for Physiology Educator Accreditation was established by the Physiological Society of Japan in 2013 and then implemented. The accreditation process starts by the applicant participating in the education program during the society’s annual meeting, after which the applicant’s teaching and research experiences are reviewed. The education program consists of model lectures to learn teaching skills and lectures to obtain up-to-date knowledge about physiology. The main purpose of the system is to provide an opportunity to obtain a wide range of knowledge and skills for physiology teaching for teachers working at medical universities and universities of life sciences and for young researchers aiming for a tenure-track academic position.
7.Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan.
Kenichi HARANO ; Akihiro HIRAKAWA ; Takayuki KATO ; Keisuke SUZUKI ; Sachiko WATANABE ; Noriyuki KATSUMATA
Journal of Gynecologic Oncology 2014;25(2):124-129
OBJECTIVE: To assess the use of colony-stimulating factors (CSFs) in patients with ovarian cancer who receive adjuvant paclitaxel and carboplatin chemotherapy in clinical practice and to assess whether the frequency of CSF use differs among hospitals in Japan. METHODS: CSF use in patients with ovarian cancer who received first-line paclitaxel and carboplatin was analyzed retrospectively using data from the Japanese hospitalization payment system. RESULTS: A total of 1,050 patients at 104 hospitals were identified. The median age was 60 years (range, 22 to 88 years). Of these, 163 patients (15.5%) were diagnosed with neutropenia and 134 patients (12.8%) received CSFs. Among the patients who received CSFs, 125 (93%) received them for the treatment of neutropenia without fever and 1 received them for febrile neutropenia. In total, CSFs were administered for 272 cycles of chemotherapy. Among them, CSFs were used as treatment for neutropenia without fever in 259 cycles (95%), as prophylaxis (primary or secondary) in 12 cycles (4%), and as treatment for febrile neutropenia in 1 cycle. Among hospitals, a median of 4.0% of patients received CSFs with an interquartile range of 25% (Q1, 0%; Q3, 25%). A logistic random effects model showed that the variation in the proportion of patients receiving CSFs among the 104 hospitals was 2.0 (p<0.001), suggesting that the use of CSFs varied across hospitals. CONCLUSION: Most patients received CSFs for neutropenia without fever. Standardized and evidence-based use of CSFs is critically required among hospitals in Japan.
Asian Continental Ancestry Group
;
Carboplatin*
;
Colony-Stimulating Factors*
;
Drug Therapy
;
Febrile Neutropenia
;
Fever
;
Hospitalization
;
Humans
;
Japan*
;
Neutropenia
;
Ovarian Neoplasms*
;
Paclitaxel*
;
Retrospective Studies
8.Giant High-Flow Type Pulmonary Arteriovenous Malformation: Coil Embolization with Flow Control by Balloon Occlusion and an Anchored Detachable Coil.
Masayuki KANEMATSU ; Hiroshi KONDO ; Satoshi GOSHIMA ; Yusuke TSUGE ; Haruo WATANABE ; Noriyuki MORIYAMA
Korean Journal of Radiology 2012;13(1):111-114
Pulmonary arteriovenous malformations (PAVMs) are often treated by pushable fibered or non-fibered microcoils, using an anchor or scaffold technique or with an Amplatzer plug through a guiding sheath. When performing percutaneous transcatheter microcoil embolization, there is a risk of coil migration, particularly with high-flow type PAVMs. The authors report on a unique treatment in a patient with a giant high-flow PAVM whose nidus had a maximum diameter of 6 cm. A detachable coil, not detached from a delivery wire (an anchored detachable coil), was first placed in the feeding artery under flow control by balloon occlusion, and then multiple microcoils were packed proximally to the anchored detachable coil. After confirming the stability of the microcoils during a gradual deflation of the balloon, we finally released the first detachable coil. The nidus was reduced in size to 15 mm at one year postoperatively.
Arteriovenous Malformations/*therapy
;
Balloon Occlusion/*methods
;
Catheterization
;
Contrast Media/diagnostic use
;
Embolization, Therapeutic/instrumentation/*methods
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Pulmonary Artery/*abnormalities
;
Pulmonary Veins/*abnormalities
;
Tomography, X-Ray Computed
9.Two Cases of Unilateral Pulmonary Edema after Heart Surgery : Successful Strategy Using Veno-venous Extracorporeal Membrane Oxygenation
Hiromasa Nakamura ; Hiroki Yamaguchi ; Tatsuya Nakao ; Yu Oshima ; Noriyuki Tokunaga ; Shinichi Mitsuyama ; Koyu Watanabe
Japanese Journal of Cardiovascular Surgery 2011;40(4):172-176
We report 2 patients with unilateral pulmonary edema after heart surgery who were successfully treated using venovenous extracorporeal membrane oxygenation (VV ECMO). Case 1 : A 35-year-old woman presented with dyspnea. Echocardiography showed severe mitral regurgitation (MR) and tricuspid regurgitation (TR) and therefore, mitral valve plasty (MVP) and tricuspid annular plasty (TAP) were performed via right thoracotomy. After weaning from cardiopulmonary bypass, respiratory failure occurred with expectoration of foamy sputum and it was difficult to maintain oxygenation. Therefore, we performed VV ECMO to maintain oxygenation. A chest X-ray film after surgery showed ipsilateral pulmonary edema. After weaning from VV ECMO, deep venous thrombosis occurred and therefore we inserted an IVC filter. Case 2 : A 67-year-old man, who had previously received aortic valve replacement experienced dyspnea and visited our hospital. Echocardiography showed an aortic root abscess, and therefore Bentall operation was performed. After weaning from cardiopulmonary bypass, oxygenation was difficult to maintain, and therefore we performed VV ECMO. A chest X-ray film post operatively showed right ipsilateral pulmonary edema. The patient was weaned from VV ECMO 5 days post operatively and was discharged 60 days post operatively. We believe that VV ECMO can be beneficial for patients with respiratory failure after heart surgery, but complications related to this approach such as DVT should also be considered.
10.Paradoxical increases in serum levels of highly chlorinated PCBs in aged women in clear contrast to robust decreases in dietary intakes from 1980 to 2003 in Japan.
Akio KOIZUMI ; Kouji H HARADA ; Bita ESLAMI ; Yoshinori FUJIMINE ; Noriyuki HACHIYA ; Iwao HIROSAWA ; Kayoko INOUE ; Sumiko INOUE ; Shigeki KODA ; Yukinori KUSAKA ; Katsuyuki MURATA ; Kazuyuki OMAE ; Norimitsu SAITO ; Shinichiro SHIMBO ; Katsunobu TAKENAKA ; Tatsuya TAKESHITA ; Hidemi TODORIKI ; Yasuhiko WADA ; Takao WATANABE ; Masayuki IKEDA
Environmental Health and Preventive Medicine 2009;14(4):235-246
OBJECTIVEExposure to polychlorinated biphenyls (PCBs) is considered to have culminated between 1950 and 1970 in Japan, and exposure through diet, the major exposure route, has decreased significantly over the last 10 years. The primary goal of the present study was to investigate the long-term trends and congener profiles of serum and dietary levels of PCBs using historical samples.
METHODSUsing banked samples collected in 1980, 1995, and 2003 surveys, we determined the daily intakes and serum concentrations of 13 PCB congeners (#74, #99, #118, #138, #146, #153, #156, #163, #164, #170, #180, #182, and #187) in women.
RESULTSThe total daily PCB intake [ng/day, geometric mean (geometric standard deviation)] decreased significantly from 523 (2.5) in 1980 to 63 (3.2) in 2003. The serum total PCB level (ng/g lipid) in women <40 years of age decreased significantly from 185 (1.8) in 1980 to 68 (1.8) in 2003. In contrast, the level in women >50 years of age increased significantly from 125 (1.7) in 1980 to 242 (1.7) in 2003. Specifically, the serum concentrations of hexa (#138, #146, #153, #156, #163, and #164) and hepta (#170, #180, #182, and #187) congeners increased significantly. A comparison of the serum PCB levels of women born from 1940 to 1953 revealed that their serum total PCB level was significantly higher in the 2003 survey [242 (1.7), n = 9] than in the 1995 [128 (2.0), n = 17] surveys. This increase in the total PCB level was attributable to increases in the hepta congener groups.
CONCLUSIONPresent results suggest a decreased rate of elimination of hepta congeners with aging in females, rather than a birth-generation phenomenon.


Result Analysis
Print
Save
E-mail